259 related articles for article (PubMed ID: 17923691)
1. Protein kinase C-dependent control of Bcl-x alternative splicing.
Revil T; Toutant J; Shkreta L; Garneau D; Cloutier P; Chabot B
Mol Cell Biol; 2007 Dec; 27(24):8431-41. PubMed ID: 17923691
[TBL] [Abstract][Full Text] [Related]
2. The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.
Shultz JC; Vu N; Shultz MD; Mba MU; Shapiro BA; Chalfant CE
Mol Cancer Res; 2012 May; 10(5):660-9. PubMed ID: 22522453
[TBL] [Abstract][Full Text] [Related]
3. The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x.
Shkreta L; Michelle L; Toutant J; Tremblay ML; Chabot B
J Biol Chem; 2011 Jan; 286(1):331-40. PubMed ID: 20980256
[TBL] [Abstract][Full Text] [Related]
4. Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.
Xiao Q; Ford AL; Xu J; Yan P; Lee KY; Gonzales E; West T; Holtzman DM; Lee JM
J Neurosci; 2012 Sep; 32(39):13587-96. PubMed ID: 23015448
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.
Cloutier P; Toutant J; Shkreta L; Goekjian S; Revil T; Chabot B
J Biol Chem; 2008 Aug; 283(31):21315-24. PubMed ID: 18534987
[TBL] [Abstract][Full Text] [Related]
6. Identification of two RNA cis-elements that function to regulate the 5' splice site selection of Bcl-x pre-mRNA in response to ceramide.
Massiello A; Salas A; Pinkerman RL; Roddy P; Roesser JR; Chalfant CE
J Biol Chem; 2004 Apr; 279(16):15799-804. PubMed ID: 14734550
[TBL] [Abstract][Full Text] [Related]
7. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.
Chalfant CE; Rathman K; Pinkerman RL; Wood RE; Obeid LM; Ogretmen B; Hannun YA
J Biol Chem; 2002 Apr; 277(15):12587-95. PubMed ID: 11801602
[TBL] [Abstract][Full Text] [Related]
8. Skipping of exon 10 in
Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
[TBL] [Abstract][Full Text] [Related]
9. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes.
Shkreta L; Froehlich U; Paquet ER; Toutant J; Elela SA; Chabot B
Mol Cancer Ther; 2008 Jun; 7(6):1398-409. PubMed ID: 18566212
[TBL] [Abstract][Full Text] [Related]
10. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
11. Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis.
Shapiro BA; Vu NT; Shultz MD; Shultz JC; Mietla JA; Gouda MM; Yacoub A; Dent P; Fisher PB; Park MA; Chalfant CE
J Biol Chem; 2016 Oct; 291(41):21669-21681. PubMed ID: 27519412
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.
Paronetto MP; Achsel T; Massiello A; Chalfant CE; Sette C
J Cell Biol; 2007 Mar; 176(7):929-39. PubMed ID: 17371836
[TBL] [Abstract][Full Text] [Related]
13. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.
Massiello A; Roesser JR; Chalfant CE
FASEB J; 2006 Aug; 20(10):1680-2. PubMed ID: 16790528
[TBL] [Abstract][Full Text] [Related]
14. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X.
Weldon C; Dacanay JG; Gokhale V; Boddupally PVL; Behm-Ansmant I; Burley GA; Branlant C; Hurley LH; Dominguez C; Eperon IC
Nucleic Acids Res; 2018 Jan; 46(2):886-896. PubMed ID: 29156002
[TBL] [Abstract][Full Text] [Related]
15. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation.
Marcelli M; Marani M; Li X; Sturgis L; Haidacher SJ; Trial JA; Mannucci R; Nicoletti I; Denner L
Prostate; 2000 Mar; 42(4):260-73. PubMed ID: 10679755
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
[TBL] [Abstract][Full Text] [Related]
18. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.
Zhou A; Ou AC; Cho A; Benz EJ; Huang SC
Mol Cell Biol; 2008 Oct; 28(19):5924-36. PubMed ID: 18663000
[TBL] [Abstract][Full Text] [Related]
19. Regulation of alternative splicing of caspase-2 through an intracellular signaling pathway in response to pro-apoptotic stimuli.
Iwanaga N; Kamachi M; Aratake K; Izumi Y; Ida H; Tanaka F; Tamai M; Arima K; Nakamura H; Origuchi T; Kawakami A; Eguchi K
J Lab Clin Med; 2005 Feb; 145(2):105-10. PubMed ID: 15746654
[TBL] [Abstract][Full Text] [Related]
20. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
Mercatante DR; Bortner CD; Cidlowski JA; Kole R
J Biol Chem; 2001 May; 276(19):16411-7. PubMed ID: 11278482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]